Bristol-Myers Squibb Gets FDA Approval for Hodgkin’s Lymphoma Treatment

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Large Cap Stocks with Highest Dividends. Bristol-Myers Squibb Gets FDA Approval for Hodgkin's Lymphoma Treatment Bristol-Myers Squibb Company (NYSE:BMY) discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company (NYSE:BMY) announced on March 20 that the U.S. Food and Drug Administration had approved the company’s combination treatment for adults and adoles ...